Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleix Prat

Showing results (61-70 of 326) with videos related to

Pageof 33
Sort By:
Oncotarget|September 8, 2016
Modeling anti-IL-6 therapy using breast cancer patient-derived xenograftsBeatriz Morancho, Mariano Zacarías-Fluck, Antonio Esgueva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Low allele frequency variants identified on germline multi-gene panel testing for cancer predisposition can suggest the presence of constitutional mosaicismAdela Rodriguez-Hernandez, Linda M Polfus, Brittany L Bychkovsky, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2024
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide surveyOlga Martínez-Sáez, Javier Cortés, Eva Ciruelos, et al.
Cancers|October 13, 2021
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with TaxanesMercedes Marín-Aguilera, María V Pereira, Natalia Jiménez, et al.
Breast Cancer Research and Treatment|October 29, 2013
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesAleix Prat, Olga Karginova, Joel S Parker, et al.
European Urology|March 8, 2016
TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate CancerÒscar Reig, Mercedes Marín-Aguilera, Gemma Carrera, et al.
European Urology|March 6, 2017
Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13]Òscar Reig, Mercedes Marín-Aguilera, Gemma Carrera, et al.
NPJ Breast Cancer|January 28, 2026
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncologyGiuseppe Di Grazia, Rodrigo Sánchez-Bayona, Climent Casals-Pascual, et al.
Molecular Oncology|October 1, 2013
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancerFilippo Montemurro, Aleix Prat, Valentina Rossi, et al.
Cancer Treatment Reviews|April 18, 2022
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?Juan Miguel Cejalvo, Claudette Falato, Lorea Villanueva, et al.
Pageof 33

Showing results (61-70 of 326) with videos related to

Sort By:
Pageof 33
Oncotarget|September 8, 2016
Modeling anti-IL-6 therapy using breast cancer patient-derived xenograftsBeatriz Morancho, Mariano Zacarías-Fluck, Antonio Esgueva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Low allele frequency variants identified on germline multi-gene panel testing for cancer predisposition can suggest the presence of constitutional mosaicismAdela Rodriguez-Hernandez, Linda M Polfus, Brittany L Bychkovsky, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 23, 2024
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide surveyOlga Martínez-Sáez, Javier Cortés, Eva Ciruelos, et al.
Cancers|October 13, 2021
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with TaxanesMercedes Marín-Aguilera, María V Pereira, Natalia Jiménez, et al.
Breast Cancer Research and Treatment|October 29, 2013
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesAleix Prat, Olga Karginova, Joel S Parker, et al.
European Urology|March 8, 2016
TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate CancerÒscar Reig, Mercedes Marín-Aguilera, Gemma Carrera, et al.
European Urology|March 6, 2017
Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13]Òscar Reig, Mercedes Marín-Aguilera, Gemma Carrera, et al.
NPJ Breast Cancer|January 28, 2026
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncologyGiuseppe Di Grazia, Rodrigo Sánchez-Bayona, Climent Casals-Pascual, et al.
Molecular Oncology|October 1, 2013
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancerFilippo Montemurro, Aleix Prat, Valentina Rossi, et al.
Cancer Treatment Reviews|April 18, 2022
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?Juan Miguel Cejalvo, Claudette Falato, Lorea Villanueva, et al.
Pageof 33